IDH3A
Basic information
Region (hg38): 15:78131498-78171945
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa 90 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Retinitis pigmentosa 90 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 28412069; 30058936; 31012789 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (8 variants)
- Retinitis pigmentosa 90 (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IDH3A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 56 | 62 | ||||
missense | 84 | 88 | ||||
nonsense | 4 | |||||
start loss | 1 | |||||
frameshift | 4 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 11 | 19 | 3 | 33 | ||
non coding | 46 | 14 | 62 | |||
Total | 8 | 6 | 90 | 105 | 18 |
Highest pathogenic variant AF is 0.0000263
Variants in IDH3A
This is a list of pathogenic ClinVar variants found in the IDH3A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-78149232-C-G | Benign (May 12, 2021) | |||
15-78149405-T-C | Uncertain significance (Jan 17, 2022) | |||
15-78149411-G-T | Uncertain significance (Oct 01, 2022) | |||
15-78149413-C-T | Uncertain significance (Feb 23, 2022) | |||
15-78149414-C-T | Uncertain significance (Jun 09, 2023) | |||
15-78149415-C-G | Likely benign (Jun 23, 2023) | |||
15-78149416-G-T | not specified | Uncertain significance (Oct 17, 2022) | ||
15-78149420-G-A | Pathogenic (Oct 22, 2021) | |||
15-78149423-T-C | Uncertain significance (Apr 28, 2022) | |||
15-78149424-C-T | Likely benign (Sep 17, 2021) | |||
15-78149427-T-C | Benign (Feb 01, 2024) | |||
15-78149429-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
15-78149432-T-C | Likely pathogenic (Nov 29, 2022) | |||
15-78149435-G-A | Uncertain significance (Jun 13, 2023) | |||
15-78149436-C-CGCTGGCAGGCCGGCGTGTGGCAG | Likely benign (Mar 23, 2021) | |||
15-78149438-CT-GG | Likely benign (Jun 15, 2023) | |||
15-78149439-T-TGGCAGGCCGGCGTGTGGCAGGCA | Likely benign (Apr 09, 2023) | |||
15-78149441-G-T | Likely benign (Mar 04, 2023) | |||
15-78149443-A-G | Likely benign (Oct 06, 2023) | |||
15-78149444-G-T | Likely benign (Jul 12, 2022) | |||
15-78149446-C-A | Likely benign (May 05, 2023) | |||
15-78149449-G-T | Likely benign (Aug 08, 2022) | |||
15-78149450-C-G | Likely benign (Oct 29, 2022) | |||
15-78149544-T-G | Benign (May 12, 2021) | |||
15-78155203-A-G | Likely benign (Aug 31, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IDH3A | protein_coding | protein_coding | ENST00000299518 | 11 | 40452 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.157 | 0.842 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.59 | 115 | 224 | 0.514 | 0.0000129 | 2404 |
Missense in Polyphen | 46 | 108.92 | 0.42232 | 1102 | ||
Synonymous | -0.220 | 83 | 80.5 | 1.03 | 0.00000494 | 701 |
Loss of Function | 2.99 | 5 | 19.1 | 0.262 | 9.57e-7 | 229 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.0000440 | 0.0000439 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalytic subunit of the enzyme which catalyzes the decarboxylation of isocitrate (ICT) into alpha-ketoglutarate. The heterodimer composed of the alpha (IDH3A) and beta (IDH3B) subunits and the heterodimer composed of the alpha (IDH3A) and gamma (IDH3G) subunits, have considerable basal activity but the full activity of the heterotetramer (containing two subunits of IDH3A, one of IDH3B and one of IDH3G) requires the assembly and cooperative function of both heterodimers. {ECO:0000269|PubMed:28139779}.;
- Pathway
- Citrate cycle (TCA cycle) - Homo sapiens (human);Warburg Effect;The oncogenic action of Succinate;The oncogenic action of Fumarate;Pyruvate dehydrogenase deficiency (E3);Pyruvate dehydrogenase deficiency (E2);2-ketoglutarate dehydrogenase complex deficiency;Mitochondrial complex II deficiency;Fumarase deficiency;Congenital lactic acidosis;Citric Acid Cycle;Glutaminolysis and Cancer;The oncogenic action of 2-hydroxyglutarate;The oncogenic action of L-2-hydroxyglutarate in Hydroxygluaricaciduria;The oncogenic action of D-2-hydroxyglutarate in Hydroxygluaricaciduria ;TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc);TCA Cycle;Citrate cycle;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;TCA cycle;TCA cycle;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle
(Consensus)
Recessive Scores
- pRec
- 0.448
Intolerance Scores
- loftool
- 0.500
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.51
Haploinsufficiency Scores
- pHI
- 0.210
- hipred
- Y
- hipred_score
- 0.707
- ghis
- 0.576
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.502
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Idh3a
- Phenotype
- vision/eye phenotype;
Gene ontology
- Biological process
- carbohydrate metabolic process;tricarboxylic acid cycle
- Cellular component
- nucleus;mitochondrion;mitochondrial matrix;myelin sheath
- Molecular function
- magnesium ion binding;isocitrate dehydrogenase (NAD+) activity;NAD binding